Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
Agilent Technologies Inc A
News
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share
Agilent to Participate in J.P. Morgan U.S. All Stars Conference
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System
Agilent Introduces the Cary 635 FTIR Spectrometer
Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo
Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
Agilent Technologies' Cancer Test Gets Expanded Approval From FDA
United States